PB125: The Herbal Nrf2 Blend That Kept Arteries Working in Bed Rest
A botanical Nrf2 activator called PB125, made from rosemary, ashwagandha and luteolin, has now been tested in a small, double-blind human trial. In 24 older adults, two weeks at 200 mg/day raised brachial FMD from 2.8% to 3.8% and popliteal FMD from 1.5% to 2.3%. During five days of bed rest, the blend preserved artery function and antioxidant levels compared with placebo. Younger adults saw no baseline FMD gain, though PB125 protected popliteal FMD during limb immobilization. With only 44 participants and surrogate endpoints, it's a promising signal rather than proof of clinical benefit.
Magnesium Eased Stiff Arteries After 6 Months—Then Came a Null Trial
For 12 weeks, magnesium did nothing measurable to arterial stiffness. At week 24, a 52-person randomized trial found pulse wave velocity improved by 1.0 m/s versus placebo, with no change in blood pressure. It's an eye-catching result for anyone interested in vascular aging. But a larger 2022 follow-up from the same group, testing 164 adults and three magnesium forms, found no significant effect. Here's what the original study showed, where it falls short, and what to make of the conflicting evidence.